VIENNA (MedPage Today) -- A drug that blocks a cell-suicide trigger in immune cells induce clinical responses and extended progression-free survival in patients with non-small cell lung cancer. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment